BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9263727)

  • 1. Superoxide dismutase activity in lymphocytes and polymorphonuclear cells of diabetic patients.
    Vucić M; Gavella M; Bozikov V; Ashcroft SJ; Rocić B
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):517-21. PubMed ID: 9263727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of oxidative stress on the endothelial dysfunction of children and adolescents with type 1 diabetes mellitus: protection by superoxide dismutase?
    Suys B; de Beeck LO; Rooman R; Kransfeld S; Heuten H; Goovaerts I; Vrints C; de Wolf D; Matthys D; Manuel-y-Keenoy B
    Pediatr Res; 2007 Oct; 62(4):456-61. PubMed ID: 17667843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in superoxide dismutase activities and concentrations and myeloperoxidase activities in leukocytes from patients with diabetes mellitus.
    Uchimura K; Nagasaka A; Hayashi R; Makino M; Nagata M; Kakizawa H; Kobayashi T; Fujiwara K; Kato T; Iwase K; Shinohara R; Kato K; Itoh M
    J Diabetes Complications; 1999; 13(5-6):264-70. PubMed ID: 10765000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant systems in polymorphonuclear leucocytes of Type 2 diabetes mellitus.
    Muchová J; Liptáková A; Országhová Z; Garaiová I; Tison P; Cársky J; Duracková Z
    Diabet Med; 1999 Jan; 16(1):74-8. PubMed ID: 10229297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CuZn superoxide dismutase, Mn superoxide dismutase, catalase and glutathione peroxidase in lymphocytes and erythrocytes in insulin-dependent diabetic children.
    Hägglöf B; Marklund SL; Holmgren G
    Acta Endocrinol (Copenh); 1983 Feb; 102(2):235-9. PubMed ID: 6338671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superoxide dismutase in diabetic polymorphonuclear leukocytes.
    Nath N; Chari SN; Rathi AB
    Diabetes; 1984 Jun; 33(6):586-9. PubMed ID: 6327438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parameters of glycemic control and their relationship with zinc concentrations in blood and with superoxide dismutase enzyme activity in type 2 diabetes patients.
    Lima VB; Sampaio Fde A; Bezerra DL; Moita Neto JM; Marreiro Ddo N
    Arq Bras Endocrinol Metabol; 2011 Dec; 55(9):701-7. PubMed ID: 22231973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of impaired trace element status on polymorphonuclear leukocyte activation in the development of vascular complications in type 2 diabetes mellitus.
    Karahan SC; Değer O; Orem A; Uçar F; Erem C; Alver A; Onder E
    Clin Chem Lab Med; 2001 Feb; 39(2):109-15. PubMed ID: 11341743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of activity, but no decrease in concentration, of erythrocyte Cu,Zn-superoxide dismutase by hyperglycaemia in diabetic patients.
    Kotake M; Shinohara R; Kato K; Hayakawa N; Hayashi R; Uchimura K; Makino M; Nagata M; Kakizawa H; Nakagawa H; Nagasaka A; Itoh M
    Diabet Med; 1998 Aug; 15(8):668-71. PubMed ID: 9702470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Exercise-induced oxidative stress and antioxidant enzyme activity in type 2 diabetic patients with and without diastolic dysfunction and hypertension].
    Kostić N; Caparavić Z; Ilić S; Radojković J; Marina Dj; Pencić B; Dekleva M
    Srp Arh Celok Lek; 2009; 137(3-4):146-51. PubMed ID: 19459560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers effectively and directly potentiate superoxide scavenging by polymorphonuclear leukocytes from patients with type 2 diabetes mellitus.
    Inukai T; Yoshida N; Wakabayashi S; Inukai Y; Matsutomo R; Takanashi K; Nakamachi T; Takebayashi K; Aso Y; Takahashi K
    Am J Med Sci; 2005 May; 329(5):222-7. PubMed ID: 15894863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change of zinc, copper, and metallothionein concentrations and the copper-zinc superoxide dismutase activity in patients with pancreatitis.
    Milnerowicz H; Jabłonowska M; Bizoń A
    Pancreas; 2009 Aug; 38(6):681-8. PubMed ID: 19629005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum superoxide dismutase levels correlate with disease severity and neutrophil degranulation in idiopathic pulmonary fibrosis.
    Borzì RM; Grigolo B; Meliconi R; Fasano L; Sturani C; Fabbri M; Porstmann T; Facchini A
    Clin Sci (Lond); 1993 Sep; 85(3):353-9. PubMed ID: 8403808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of selected components in antioxidant systems of blood in patients with diabetes].
    Majchrzak A; Zozulińska D; Wierusz-Wysocka B
    Pol Merkur Lekarski; 2001 Mar; 10(57):150-2. PubMed ID: 11398514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered antioxidant enzyme defences in insulin-dependent diabetic men with increased resting and exercise-induced oxidative stress.
    Atalay M; Laaksonen DE; Niskanen L; Uusitupa M; Hänninen O; Sen CK
    Acta Physiol Scand; 1997 Oct; 161(2):195-201. PubMed ID: 9366962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet antioxidant enzymes in insulin-dependent diabetes mellitus.
    Seghieri G; Di Simplicio P; Anichini R; Alviggi L; De Bellis A; Bennardini F; Franconi F
    Clin Chim Acta; 2001 Jul; 309(1):19-23. PubMed ID: 11408002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus.
    Maxwell SR; Thomason H; Sandler D; Leguen C; Baxter MA; Thorpe GH; Jones AF; Barnett AH
    Eur J Clin Invest; 1997 Jun; 27(6):484-90. PubMed ID: 9229228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress parameters in type I, type II and insulin-treated type 2 diabetes mellitus; insulin treatment efficiency.
    Seghrouchni I; Drai J; Bannier E; Rivière J; Calmard P; Garcia I; Orgiazzi J; Revol A
    Clin Chim Acta; 2002 Jul; 321(1-2):89-96. PubMed ID: 12031597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased glycated Cu,Zn-superoxide dismutase levels in erythrocytes of patients with insulin-dependent diabetis mellitus.
    Kawamura N; Ookawara T; Suzuki K; Konishi K; Mino M; Taniguchi N
    J Clin Endocrinol Metab; 1992 Jun; 74(6):1352-4. PubMed ID: 1592880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications.
    Colak E; Majkić-Singh N; Stanković S; Srecković-Dimitrijević V; Djordjević PB; Lalić K; Lalić N
    Ann Med; 2005; 37(8):613-20. PubMed ID: 16338763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.